Clinical Trial Update: Clinical Controlled Study on the Efficacy of Denosumab in Treating Osteoporosis in the Domestic Population and Its Impact on Sarcopenia-related Outcomes [Phase 3]

View source ↗

Summary

A Phase 3 controlled trial evaluating denosumab for osteoporosis and its impact on sarcopenia-related outcomes in the domestic population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Sarcopenia

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Sarcopenia, Osteoporosis | Phase 3 | Status: UNKNOWN